Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Clinical trial NCT06435702 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06435702
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-07-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.